West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

Press releases published on July 14, 2026

Jul. 14, 2026

Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026

Indeterminate GlobeNewswire

Jul. 14, 2026

Dandy Unveils Polychromatic Shade™ to End the Trade-Off Between Dental Aesthetics and Affordability

Indeterminate GlobeNewswire

Jul. 14, 2026

QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company

Indeterminate GlobeNewswire

Jul. 14, 2026

Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Indeterminate GlobeNewswire

Jul. 14, 2026

Visory Health Wins a Digital Health Award for Second Consecutive Year

Indeterminate GlobeNewswire

Jul. 14, 2026

Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026

Indeterminate GlobeNewswire

Jul. 14, 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 14, 2026

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

Indeterminate GlobeNewswire

Jul. 14, 2026

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

Indeterminate GlobeNewswire

Jul. 14, 2026

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

Indeterminate GlobeNewswire

Jul. 14, 2026

FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer

Indeterminate GlobeNewswire

Jul. 14, 2026

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Indeterminate GlobeNewswire

Jul. 14, 2026

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

Indeterminate GlobeNewswire

Jul. 14, 2026

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Jul. 14, 2026

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

Jul. 14, 2026

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire

Jul. 14, 2026

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire

Jul. 14, 2026

Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry

Indeterminate GlobeNewswire

Jul. 14, 2026

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire